Bioconjugation

Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar without the common side effects of nausea, vomiting, and in select cases, undesired weight loss.

Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the introduction of Bioregister 2020.1, the latest version of its web-based application for registering sequence-based, chemically modified and structure-less biological entities.

Chemist develops potential drug to treat type 2 diabetes without harsh side effects.  BrinkwireChemist develops potential drug to treat type 2 diabetes without harsh side effects  Medical XpressView Full coverage on Google News